These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. In vitro and in vivo functions of thrombin-treated platelets. Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the interactions of fibrinogen and soluble fibrin with washed rabbit platelets stimulated with ADP. Harfenist EJ; Packham MA; Mustard JF Thromb Haemost; 1985 Apr; 53(2):183-7. PubMed ID: 3927504 [TBL] [Abstract][Full Text] [Related]
5. Concentration effects of platelets, fibrinogen and thrombin on platelet aggregation and fibrin clotting. Chao FC; Tullis JL; Kenney DM; Conneely GS; Doyle JR Thromb Diath Haemorrh; 1974 Sep; 32(1):216-31. PubMed ID: 4454041 [TBL] [Abstract][Full Text] [Related]
6. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents. Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085 [TBL] [Abstract][Full Text] [Related]
7. Unexpected effects of aurin tricarboxylic acid on human platelets. Kinlough-Rathbone RL; Packham MA Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166 [TBL] [Abstract][Full Text] [Related]
8. Factors influencing the deaggregation of human and rabbit platelets. Kinlough-Rathbone RL; Mustard JF; Perry DW; Dejana E; Cazenave JP; Packham MA; Harfenist EJ Thromb Haemost; 1983 Jun; 49(3):162-7. PubMed ID: 6308846 [TBL] [Abstract][Full Text] [Related]
9. ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb. Teng CM; Kang YF; Chang YL; Ko FN; Yang SC; Hsu FL Thromb Haemost; 1997 Mar; 77(3):555-61. PubMed ID: 9066010 [TBL] [Abstract][Full Text] [Related]
10. Characteristics of thrombin-degranulated human platelets: development of a method that does not use proteolytic enzymes for deaggregation. Kinlough-Rathbone RL; Packham MA; Guccione MA; Richardson M; Harfenist EJ; Mustard JF Thromb Haemost; 1991 Apr; 65(4):403-10. PubMed ID: 2057923 [TBL] [Abstract][Full Text] [Related]
11. Lack of stability of aggregates after thrombin-induced reaggregation of thrombin-degranulated platelets. Kinlough-Rathbone RL; Packham MA; Perry DW; Mustard JF; Cattaneo M Thromb Haemost; 1992 Apr; 67(4):453-7. PubMed ID: 1631794 [TBL] [Abstract][Full Text] [Related]
12. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes. Winocour PD; Kinlough-Rathbone RL; Mustard JF J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538 [TBL] [Abstract][Full Text] [Related]
13. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN. Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653 [TBL] [Abstract][Full Text] [Related]